The treatment of acute diarrhoea begins with correction and maintenance of rehydration, but the appropriate diet thereafter is debated. ' It has been suggested that the optimal diet should include fermented milks as they are low in lactose, their proteins are more easily digested, and they seem to The preparations of L casei strain GG were manufactured by the Research and Development Centre of Valio Ltd, Helsinki, Finland, as follows. L casei strain GG was concentrated, washed with water, and the concentrate divided into two. One half was heated to 85-100°C for 10 min. Saccharose was added as a cryoprotectant into both halves (about 50% of dry matter), and both preparations were lyophilised. The viable half, that was not heat treated, contained 1 x 10 1 1 cfu/g L casei strain GG, whereas the heat inactivated half did not contain living bacteria. Both preparations were divided into 0 1 g aliquots and stored at -180C until reconstitution and administration in tap water (about 5 ml). The appearance and taste of these solutions were indistinguishable.
Heparinised blood was drawn for the enzyme linked immunospot (ELISPOT) assay during the acute phase (day 1 after admission) (n= 12 in group A, n=1 1 in group B), and at follow up one month later (n= 12 in group A, n= 13 in group B). During diarrhoea measurement of the rotavirus specific response was possible in nine and eight patients, respectively. For rotavitus antibody studies paired sera were available from 11 patients in group A and six patients in group B.
The ELISPOT assays measuring the number of lymphocytes secreting immunoglobulins of isotypes IgM, IgA, and IgG (immunoglobulin secreting cells) and the number of lymphocytes secreting specific antibodies to rotavirus (specific antibody secreting cells) were carried out as described previously.3
Rotavirus IgA and IgG serum antibodies were measured using an enzyme linked immunosorbent assay (ELISA) method, which was a single serum dilution modification of the test described by Midthun et al. 5 The antigen was a rhesus human reassortant rotavirus strain D x RRV (a reassortant between D there was no difference between the patients receiving viable and inactivated L casei strain GG (table 1) .
IMMUNOLOGICAL OUTCOME At the acute stage, the concentrations of immunoglobulin secreting cells of isotypes IgM, IgA, and IgG were high in both treatment groups. There was a tendency to a greater response in group A than in group B, although the difference was not statistically significant. The transient nature of this response was demonstrated by a significant decrease in the number of immunoglobulin secreting cells by convalescence compared with values during diarrhoea; the two treatment groups were alike (data not shown). During diarrhoea, the mean numbers of specific antibody secreting cells to rotavirus/1 06 cells were similar in both groups (data not shown). The IgM and IgG specific antibody secreting cells to rotavirus could not be detected at convalescence in either treatment group.
Very low numbers of IgA secreting cells to rotavirus were seen during diarrhoea in both treatment groups alike. By convalescence, there was a 5-4-fold increase in the number of these cells in group A compared with group B, with a risk ratio of 5-4 (95% CI from 1-5 to 19-9). Most patients in group A, but not in group B, showed a detectable rotavirus specific antibody secreting cells response at the convalescent stage.
All patients had a detectable ELISA IgA response to rotavirus from the acute to the convalescent stage ( The most interesting result of the present study is that viable L casei strain GG enhanced the rotavirus specific IgA secreting cell response and the serum IgA antibody response to rotavirus. Therefore, using viable L casei strain GG as an adjunct in the diet during acute rotavirus diarrhoea may promote development of immunity against reinfections.10 In this study, clinical recovery from rotavirus diarrhoea was equal in the two groups receiving viable or heat inactivated L casei strain GG during the diarrhoea. However, in developing countries using heat inactivated L casei strain GG might obviate the need to preserve viability of the bacteria, while maintaining the beneficial clinical effect.
